A prospective cohort study of the effect of vincristine on audition

Anti-Cancer Drugs

Volumn 7, Issue 5, 1996, Pages 525-526

  Lugassy, Gilles ^a,b   Shapira, Amnon ^a,b  

^a BARZILAI MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

ototoxicity; vincristine

Indexed keywords

VINCRISTINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HODGKIN DISEASE; HUMAN; MALE; NONHODGKIN LYMPHOMA; OTOTOXICITY; PRIORITY JOURNAL;

EID: 0029840404     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199607000-00005     Document Type: Article

References (7)

1. Legha SS. Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol 1986; 1: 421-7.
2. Rosenthal M, Kaufman S. Vincristine neurotoxicity. Ann Intern Med 1974; 80: 733-7.
3. Haim N, Barron SA, Robinson E. Muscle cramps associated with vincristine therapy. Acta Oncol 1991; 30: 707-11.
4. McCarthy GM, Skillings JR. A prospective cohort study of the orofacial effects of vincristine neurotoxicity. J Oral Pathol Med 1991; 20: 345-9.
5. Weintraub M, Adde MA, Venzon DJ, et al. Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine. J Clin Oncol 1996; 14: 935-40.
6. Soysal T, Ferhanoglu, Bilir M, Akman N. Oculomotor nerve palsy associated with vincristine treatment. Acta Haematol 1993; 90: 209-10.
7. Lugassy G, Shapira A. Sensorineural hearing loss associated with vincristine treatment. Blut 1990; 61: 320-1.